Telesis Bio Inc

NASDAQ: TBIO    
Share price (6/17/24): $3.71    
Market cap (6/17/24): $6.243 million
Search in Documents
Key Exhibits
External Links
7 Telesis Bio Inc Expert Interviews, now on BamSEC.
 Powered by Tegus.

Material Contracts Filter

EX-10.12
from 10-K 5 pages Telesis Bio Inc. Amended and Restated Outside Director Compensation Policy (Adopted on May 26, 2021, Effective Upon the Effectiveness of the Registration Statement Relating to the Company’s Initial Public Offering (The “Original Effective Date”); Most Recently Amended on May 1, 2022)
12/34/56
EX-10.1
from 8-K 3 pages August 10, 2023 Bill Kullback Sent via Email to Bkullback@yahoo.com Re: Offer of Employment Dear Bill
12/34/56
EX-10.2
from 10-Q 12 pages Certain Identified Information Marked With [***] Has Been Excluded From This Agreement Because It Is Not Material and Is of the Type That the Registrant Treats as Private and Confidential
12/34/56
EX-10.1
from 10-Q 10 pages Certain Identified Information Marked With [***] Has Been Excluded From This Agreement Because It Is Not Material and Is of the Type That the Registrant Treats as Private and Confidential
12/34/56
EX-10.3
from 8-K 7 pages Telesis Bio Inc. Amendment No. 1 to Amended and Restated Investors’ Rights Agreement
12/34/56
EX-10.2
from 8-K 29 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 43 pages Background
12/34/56
EX-10.1
from 8-K 3 pages May 2, 2022 Eric Esser Sent via Email: *** Re: Offer of Employment Dear Eric
12/34/56
EX-10.2
from 10-Q 135 pages Certain Identified Information Marked With [***] Has Been Excluded From This Exhibit Because It Is Not Material and Is of the Type That the Registrant Treats as Private and Confidential
12/34/56
EX-10.1
from 10-Q 143 pages Certain Identified Information Marked With [***] Has Been Excluded From This Exhibit Because It Is Not Material and Is of the Type That the Registrant Treats as Private and Confidential
12/34/56
EX-10.1
from 10-Q 6 pages Codex Dna, Inc. Amended and Restated Outside Director Compensation Policy (Adopted on May 26, 2021, Effective Upon the Effectiveness of the Registration Statement Relating to the Company’s Initial Public Offering (The “Original Effective Date”); Most Recently Amended on May 1, 2022)
12/34/56
EX-10.1
from 8-K 10 pages Material contract
12/34/56
EX-10.21
from 10-K 95 pages Material contract
12/34/56
EX-10.2
from 10-Q 8 pages Material contract
12/34/56
EX-10.1#
from 8-K 8 pages Agreement
12/34/56
EX-10.1
from 10-Q 127 pages Biomed Realty Form Dated 5/12/21 Lease by and Between Bre-Bmr Wateridge Pointe LP, a Delaware Limited Partnership and Codex Dna, Inc., a Delaware Corporation
12/34/56
EX-10.4
from S-8 21 pages Codex Dna, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.3
from S-8 53 pages Codex Dna, Inc. 2021 Stock Incentive Plan
12/34/56
EX-10.2
from S-8 29 pages Codex Dna, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.1
from S-8 33 pages Sgi-Dna, Inc. 2019 Stock Plan Adopted on March 08, 2019
12/34/56